Idsa Education And Research Foundation

NATION'S LEADING NON-PROFIT ORGANIZATION COMMITTED TO REDUCING THE BURDENS OF INFECTIOUS DISEASES.

MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE GRANTTHE MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE GRANT PROGRAM WAS DEVELOPED TO SUPPORT INNOVATIVE RESEARCH THAT MAY LINK INFECTIOUS DISEASE AND ALZHEIMER'S DISEASE. THIS RESEARCH INCLUDES BASIC, CLINICAL AND OR NON-TRADITIONAL RESEARCH APPROACHES ACROSS A WIDE RANGE OF HEALTH FILES WHICH INCLUDES INFECTIOUS DISEASES, NEUROLOGY, MICROBIOLOGY, PATHOLOGY, VIROLOGY AND NEUROSURGERY.IN 2021, THE IDSA FOUNDATION AWARDED MORE THAN $1.7 MILLION IN GRANT FUNDS TO RESEARCHERS WHO WERE INVESTIGATING POSSIBLE LINKAGES BETWEEN INFECTIOUS DISEASES AND THE CAUSE OF ALZHEIMER'S DISEASE. SUBMITTED APPLICATIONS WERE REVIEWED AND SCORED BY A PANEL OF EXPERTS, THE GRANT'S ADVISORY BOARD AND THE IDSA FOUNDATION BOARD OF DIRECTORS. OF THE 78 APPLICATIONS RECEIVED, 11 RECEIVED GRANTS RANGING FROM $30,000 TO $250,000 FOR EARLY CAREER AND SENIOR LEVEL INVESTIGATORS. AWARD AMOUNTS ARE BASED ON THE MERIT OF THE RESEARCH.

G.E.R.M PROGRAMTHE G.E.R.M. PROGRAM WAS DEVELOPED TO PROVIDE GRANTS TO MEDICAL STUDENTS TO SUPPORT A LONGITUDINAL, MENTORED CLINICAL LEARNING AND/OR RESEARCH PROJECT FOR UP TO ONE YEAR ON INFECTIOUS DISEASES-RELATED TOPICS, INCLUDING HIV, UNDER THE MENTORSHIP OF AN IDSA OR HIVMA MEMBER. IN 2021, 40 AWARDEES RECEIVED A $4,000 STIPEND TO COMPLETE THEIR PROJECT.THE GOALS OF THE G.E.R.M. PROGRAM ARE TO INCREASE INTEREST AMONG UNDERGRADUATE MEDICAL STUDENTS, PARTICULARLY AMONG POPULATIONS UNDERREPRESENTED IN MEDICINE, IN PURSUING ID FELLOWSHIP POST-GRADUATE TRAINING OR A CAREER IN HIV MEDICINE BY: -PROVIDING MEDICAL STUDENTS WITH A MENTOR-BASED PROGRAM TO ENCOURAGE AND FACILITATE THE PURSUIT OF A CAREER IN THE FIELD OF INFECTIOUS DISEASES.-INCREASING THE NUMBER AND DIVERSITY OF ID AND HIV RESEARCH AND CLINICAL LEARNING OPPORTUNITIES AVAILABLE TO MEDICAL STUDENTS, INCLUDING THROUGH A DIVERSE RANGE OF GEOGRAPHIC SETTINGS, PROGRAM SIZES AND ACADEMIC FOCI; AND PROVIDING ID AND HIV RESEARCH, CLINICAL LEARNING OPPORTUNITIES, MENTORSHIP AND SUPPORT TO A DIVERSE POPULATION OF MEDICAL STUDENTS, WITH A FOCUS ON THOSE CURRENTLY UNDERREPRESENTED IN THE FIELD.-SUPPORTING MEDICAL STUDENTS IN INCREASING ANALYTICAL, RESEARCH AND CLINICAL SKILLS THAT WILL IMPACT THEIR FUTURE CAREER TRAJECTORY.RESEARCH STUDIES MUST FOCUS ON PEDIATRIC OR ADULT INFECTIOUS DISEASES, INCLUDING HIV, AND MAY INVOLVE EITHER CLINICAL OR RESEARCH ACTIVITIES. ELIGIBLE PROJECT CATEGORIES INCLUDE BASIC SCIENCE, EPIDEMIOLOGY/CLINICAL RESEARCH, MEDICAL EDUCATION, STRUCTURED CLINICAL EXPERIENCES AND QUALITY IMPROVEMENT/PROGRAM EVALUATION. AWARDEES RECEIVE A $4,000 STIPEND TO COMPLETE THEIR PROJECT.APPLICANTS MUST BE MEDICAL STUDENTS (FIRST-, SECOND- OR THIRD YEAR AND THOSE IN COMBINED DEGREE PROGRAMS, INCLUDING MD/MPH AND MD/PHD) FROM AN ACCREDITED ALLOPATHIC OR OSTEOPATHIC MEDICAL SCHOOL IN THE U.S.

THE HIV CLINICAL FELLOWSHIP PROGRAM THE HIV CLINICAL FELLOWSHIP PROGRAM IS PART OF A MULTI-PRONGED IDSA EFFORT TO END THE SPREAD OF HIV BY MAXIMIZING THERAPEUTIC AND PREVENTIVE EFFORTS. TO THAT END, THE HIV CLINICAL FELLOWSHIP PROGRAM PROVIDES NON-ID-TRAINED PHYSICIANS WITH THE MOST UPDATED BEST PRACTICES FOR TREATING PATIENTS LIVING WITH HIV. IN ADDITION TO MANAGEMENT OF ANTIRETROVIRAL THERAPY, CLINICAL TRAINING ALSO INCLUDES TREATING COMMON CO-INFECTIONS AND COMORBIDITIES, SUCH AS HEPATITIS C, MENTAL HEALTH, SUBSTANCE USE DISORDER AND MULTIDISCIPLINARY TEAM PATIENT MANAGEMENT. DURING THE TRAINING YEAR, FELLOWS MANAGE THE CARE OF A MINIMUM OF 30 PATIENTS WITH HIV INFECTION UNDER THE SUPERVISION OF AN HIVMA MEMBER MENTOR. EACH YEAR OUR PROGRAM PROVIDES ONE-YEAR GRANTS TO UP TO TWO FELLOWS AT INSTITUTIONS THAT PREDOMINANTLY SERVE UNDERREPRESENTED COMMUNITIES, BLACK/AFRICAN AMERICAN AND LATINX. TO DATE, THE PHYSICIANS TRAINED THROUGH THE CLINICAL FELLOWSHIP PROGRAM HAVE REMAINED IN HIV MEDICINE AND PRIMARILY WORK IN CLINICS WITH A FOCUS ON UNDERSERVED PATIENT POPULATIONS.

IDEA INCUBATOR PROGRAMIDEA INCUBATOR IS A PITCH-STYLE COMPETITION. THE PROGRAM ENCOURAGES INNOVATORS AND EARLY-STAGE PROJECTS WITH ORIGINAL INVENTIONS, PRODUCTS AND IDEAS WITH THE POTENTIAL TO IMPROVE INFECTIOUS DISEASES CARE TO SHARE THEIR IDEAS. THESE PROJECTS ARE SHARED WITH THE INFECTIOUS DISEASES COMMUNITY AND JUDGED BY BUSINESSES, MEDICAL AND TECHNOLOGY INDUSTRIES. THE COMPETITION WAS HELD VIRTUALLY DURING THE IDWEEK CONFERENCE IN 2021.THREE WINNING TEAMS RECEIVED MONETARY AWARDS FOR THEIR INNOVATIVE IDEAS. FIRST PLACE RECEIVED $10,000, SECOND PLACE RECEIVED $5,000 AND THIRD PLACE RECEIVED $2,500.FIRST PLACE WINNER WAS AWARDED $10,000 FOR MOLECULAR IMAGING OF BACTERIAL INFECTIONS. THE TEAM DEVELOPED A PATENT-PENDING BACTERIA-SPECIFIC PET IMAGING TECHNOLOGY THAT DIFFERENTIATES GRAM-NEGATIVE BACTERIAL INFECTIONS FROM OTHER DISEASES, SUCH AS CANCER METASTASES AND TUMORS THAT DOES NOT REQUIRE SURGERY OR BIOPSY. IT HAS NEARLY 100%SPECIFICITY, AND IT CAN DETECT INFECTIONS ANYWHERE IN THE BODY WITH RAPID RESULTS AVAILABLE WITHIN THE SAME DAY. SECOND PRIZE RECEIVED $5,000 FOR: CELL-BASED BIO-ELECTRIC BIOSENSOR FOR THE DETECTION OF THE SARS-COV-2 S1 SPIKE PROTEIN ANTIGENTHIRD PRIZE RECEIVED $2,500 FOR 3RDPLACE: NEONATAL ANTIBIOTIC STEWARDSHIP APP (NASA).